Africa's Deadly Medicine Crisis: New Summit Targets 1 Million Annual Deaths
Continental summit aims to tackle substandard and falsified medicines harming millions
One million people die across Africa every year from substandard and falsified medicines. That figure, drawn from World Health Organization estimates, sits at the centre of a continent-wide crisis that Medicines for Africa is now moving to address through a landmark gathering in Rwanda.
The scale of the problem is hard to overstate. The WHO estimates that between 10 and 30 percent of medicines in low- and middle-income countries are substandard or falsified, and Africa accounts for 42 percent of such products detected globally. The economic damage runs to more than 200 billion US dollars annually. Behind those numbers are patients, families and communities bearing the consequences of systems that have failed to keep medicines safe.
The human cost surfaces most sharply in specific cases. In The Gambia, 70 children died after receiving contaminated cough syrup, a tragedy that shows how quickly a medicines safety failure becomes a mass casualty event. A separate multi-country analysis across Kenya, Ethiopia, Cameroon and Malawi found that up to 20 percent of sampled cancer medicines, drawn from both formal and informal supply chains, were substandard or falsified. Cancer patients seeking treatment, in other words, faced a one-in-five chance that what they received would not work, or would actively harm them.
The danger does not stop at counterfeit products. Weak pharmacovigilance systems, poor market surveillance and vulnerable supply chains all generate preventable harm of their own, contributing to treatment failure, antimicrobial resistance, avoidable healthcare costs and eroded public trust in health systems. These failures reinforce one another, and fragmented responses have not been enough.
What changes in September 2026: Medicines for Africa will convene the inaugural Africa Patient Safety Summit on September 16 and 17 at the Kigali Convention Centre in Rwanda. Hosted in partnership with the African Medicines Agency, the Summit will bring together regulators, governments, healthcare professionals, pharmaceutical manufacturers, researchers, digital health innovators, patient organisations and development partners under the theme “Advancing Patient Safety Through Collective Action to Prevent Medication-Related Harm.”
The timing is deliberate. The establishment of the African Medicines Agency, accelerating regulatory harmonisation across borders and rapid advances in digital health have created an opening to build stronger medicines safety systems at continental scale. Those same developments also introduce new risks, and the Summit is designed to ensure that safety keeps pace with expanding access to treatment.
Three strategic priorities will shape the agenda: preventing medication-related harm, strengthening patient-centred regulation and driving coordinated action across Africa’s medicines ecosystem. The aim is to replace fragmented national and regional efforts with genuine alignment between continental regulatory leadership, technical expertise and multi-stakeholder collaboration.
The Summit is expected to produce four concrete outputs. A Kigali Declaration on Patient Safety and Medication-Related Harm will set out shared commitments. An Africa Roadmap for Preventing Medication-Related Harm will translate those commitments into a plan. A Blueprint for Safer Medicines Use and Patient Protection will offer practical guidance for implementation. A Continental Patient Safety Coordination Network will provide the institutional structure to sustain the effort beyond the Summit itself. Together, these outputs are intended to give governments, regulators and healthcare systems a framework they can act on.
Medicines for Africa frames its role as a convening institution, one that connects evidence, technical expertise and frontline experience to drive practical change. Its position is direct: medicines must not only reach patients, but what reaches them must be safe, effective and trusted.
For the millions of Africans who depend on medicines for their health and survival, the Summit’s most important question may be the one that follows the declarations and roadmaps. Whether the coordination network it creates proves durable enough to hold governments and regulators to account, long after the Kigali Convention Centre empties, will determine whether this gathering marks a genuine turning point or another well-intentioned beginning.
Q&A
How many people die annually in Africa from substandard and falsified medicines?
One million people die across Africa every year from substandard and falsified medicines, according to World Health Organization estimates.
What specific incident in The Gambia illustrates the human cost of medicines safety failures?
In The Gambia, 70 children died after receiving contaminated cough syrup, demonstrating how quickly a medicines safety failure becomes a mass casualty event.
When and where will the inaugural Africa Patient Safety Summit take place?
The inaugural Africa Patient Safety Summit will be held on September 16 and 17, 2026 at the Kigali Convention Centre in Rwanda.
What four concrete outputs is the Summit expected to produce?
The Summit is expected to produce a Kigali Declaration on Patient Safety and Medication-Related Harm, an Africa Roadmap for Preventing Medication-Related Harm, a Blueprint for Safer Medicines Use and Patient Protection, and a Continental Patient Safety Coordination Network.